NO954538D0 - N-p-halobenzoylmetylderivater av 4-(p-fluorfenyl)-3-((3,4-metylendioksy)fenoksy)metyl)piperidin - Google Patents
N-p-halobenzoylmetylderivater av 4-(p-fluorfenyl)-3-((3,4-metylendioksy)fenoksy)metyl)piperidinInfo
- Publication number
- NO954538D0 NO954538D0 NO954538A NO954538A NO954538D0 NO 954538 D0 NO954538 D0 NO 954538D0 NO 954538 A NO954538 A NO 954538A NO 954538 A NO954538 A NO 954538A NO 954538 D0 NO954538 D0 NO 954538D0
- Authority
- NO
- Norway
- Prior art keywords
- pct
- halobenzoylmethyl
- methylenedioxy
- fluorophenyl
- piperidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES09400582A ES2102295B1 (es) | 1994-03-18 | 1994-03-18 | Nuevos compuestos derivados de la n-benzoilmetil-piperidina. |
PCT/EP1995/001007 WO1995025732A1 (en) | 1994-03-18 | 1995-03-17 | N-p-HALOBENZOYLMETHYL DERIVATIVES OF 4-(p-FLUOROPHENYL)-3-((3,4-METHYLENE-DIOXY)PHENOXY)METHYL)PIPERIDINE |
Publications (3)
Publication Number | Publication Date |
---|---|
NO954538D0 true NO954538D0 (no) | 1995-11-10 |
NO954538L NO954538L (no) | 1995-11-10 |
NO308002B1 NO308002B1 (no) | 2000-07-03 |
Family
ID=8285616
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO954538A NO308002B1 (no) | 1994-03-18 | 1995-11-10 | N-p-halogenbenzoylmetylderivater av 4-(p-fluorfenyl)-3-[[3,4- metylendioksy)fenoksy]metyl]piperidin, farmasøytisk preparat inneholdende slike derivater, og anvendelse derav |
Country Status (19)
Country | Link |
---|---|
US (1) | US5665736A (no) |
EP (1) | EP0699198B1 (no) |
JP (1) | JP3213324B2 (no) |
KR (1) | KR0182093B1 (no) |
AT (1) | ATE181734T1 (no) |
AU (1) | AU678320B2 (no) |
CA (1) | CA2163253C (no) |
DE (1) | DE69510510T2 (no) |
DK (1) | DK0699198T3 (no) |
ES (1) | ES2102295B1 (no) |
FI (1) | FI108862B (no) |
GR (1) | GR3031282T3 (no) |
IL (1) | IL112763A (no) |
NO (1) | NO308002B1 (no) |
NZ (1) | NZ283130A (no) |
PH (1) | PH31388A (no) |
TW (1) | TW416956B (no) |
WO (1) | WO1995025732A1 (no) |
ZA (1) | ZA951963B (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2117557B1 (es) * | 1996-02-29 | 1999-07-01 | Ferrer Int | Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina. |
DE69739561D1 (de) | 1996-06-13 | 2009-10-15 | Sumitomo Chemical Co | Piperidin Derivative als Zwischenprodukte zur Herstellung von Paroxetine und Verfahren zu ihrer Herstellung |
GB9623359D0 (en) * | 1996-11-09 | 1997-01-08 | Smithkline Beecham Plc | Novel process |
GB9700690D0 (en) | 1997-01-15 | 1997-03-05 | Smithkline Beecham Plc | Novel process |
AP9901698A0 (en) | 1997-05-29 | 1999-12-31 | Smithkline Beecham Corp | Novel process. |
GB9826175D0 (en) * | 1998-11-28 | 1999-01-20 | Smithkline Beecham Plc | Novel process |
AU9087301A (en) | 2000-09-11 | 2002-03-26 | Sepracor Inc | Ligands for monoamine receptors and transporters, and methods of use thereof |
US7294637B2 (en) | 2000-09-11 | 2007-11-13 | Sepracor, Inc. | Method of treating addiction or dependence using a ligand for a monamine receptor or transporter |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
EP0190496A3 (en) * | 1984-12-13 | 1987-05-27 | Beecham Group Plc | Piperidine derivatives having a gastro-intestinal activity |
ES2058061T3 (es) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | Derivado de piperidina, su preparacion y su uso como medicamento. |
IE66332B1 (en) * | 1986-11-03 | 1995-12-27 | Novo Nordisk As | Piperidine compounds and their preparation and use |
DK231088D0 (da) * | 1988-04-28 | 1988-04-28 | Ferrosan As | Piperidinforbindelser, deres fremstilling og anvendelse |
US5017585A (en) * | 1986-11-03 | 1991-05-21 | Novo Nordisk A/S | Method of treating calcium overload |
-
1994
- 1994-03-18 ES ES09400582A patent/ES2102295B1/es not_active Expired - Fee Related
-
1995
- 1995-02-21 TW TW084101572A patent/TW416956B/zh active
- 1995-02-23 IL IL112763A patent/IL112763A/en not_active IP Right Cessation
- 1995-02-27 PH PH51032A patent/PH31388A/en unknown
- 1995-03-09 ZA ZA951963A patent/ZA951963B/xx unknown
- 1995-03-17 AT AT95928869T patent/ATE181734T1/de not_active IP Right Cessation
- 1995-03-17 DK DK95928869T patent/DK0699198T3/da active
- 1995-03-17 US US08/557,008 patent/US5665736A/en not_active Expired - Fee Related
- 1995-03-17 JP JP52437595A patent/JP3213324B2/ja not_active Expired - Fee Related
- 1995-03-17 KR KR1019950705161A patent/KR0182093B1/ko not_active IP Right Cessation
- 1995-03-17 EP EP95928869A patent/EP0699198B1/en not_active Expired - Lifetime
- 1995-03-17 DE DE69510510T patent/DE69510510T2/de not_active Expired - Fee Related
- 1995-03-17 CA CA002163253A patent/CA2163253C/en not_active Expired - Fee Related
- 1995-03-17 WO PCT/EP1995/001007 patent/WO1995025732A1/en active IP Right Grant
- 1995-03-17 NZ NZ283130A patent/NZ283130A/en unknown
- 1995-03-17 AU AU21094/95A patent/AU678320B2/en not_active Ceased
- 1995-11-08 FI FI955387A patent/FI108862B/fi not_active IP Right Cessation
- 1995-11-10 NO NO954538A patent/NO308002B1/no unknown
-
1999
- 1999-09-22 GR GR990402380T patent/GR3031282T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
PH31388A (en) | 1998-10-29 |
CA2163253C (en) | 2004-08-10 |
AU2109495A (en) | 1995-10-09 |
ATE181734T1 (de) | 1999-07-15 |
ES2102295B1 (es) | 1998-04-01 |
US5665736A (en) | 1997-09-09 |
NZ283130A (en) | 1996-11-26 |
FI955387A (fi) | 1995-11-08 |
FI108862B (fi) | 2002-04-15 |
DE69510510T2 (de) | 1999-11-18 |
IL112763A (en) | 1998-03-10 |
AU678320B2 (en) | 1997-05-22 |
WO1995025732A1 (en) | 1995-09-28 |
JPH08510477A (ja) | 1996-11-05 |
DE69510510D1 (de) | 1999-08-05 |
NO308002B1 (no) | 2000-07-03 |
ES2102295A1 (es) | 1997-07-16 |
GR3031282T3 (en) | 1999-12-31 |
IL112763A0 (en) | 1995-05-26 |
FI955387A0 (fi) | 1995-11-08 |
DK0699198T3 (da) | 1999-11-22 |
KR0182093B1 (ko) | 1999-05-01 |
NO954538L (no) | 1995-11-10 |
TW416956B (en) | 2001-01-01 |
ZA951963B (en) | 1996-03-11 |
EP0699198A1 (en) | 1996-03-06 |
CA2163253A1 (en) | 1995-09-28 |
JP3213324B2 (ja) | 2001-10-02 |
EP0699198B1 (en) | 1999-06-30 |
KR960702456A (ko) | 1996-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0696281T3 (da) | Hidtil ukendte 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazolderivater | |
ATE206611T1 (de) | Verwendung von mangiferin oder seinen derivaten zur kosmetischen anwendung | |
AU679761B2 (en) | 3,5-dioxo-(2H,4H)-1,2,4-triazine derivatives as 5HT1A ligands | |
CA2067758A1 (en) | Piperidine and pyrrolidine derivatives | |
NO954538D0 (no) | N-p-halobenzoylmetylderivater av 4-(p-fluorfenyl)-3-((3,4-metylendioksy)fenoksy)metyl)piperidin | |
NO308001B1 (no) | Nye kromenforbindelser, deres anvendelse for fremstilling av et preparat samt farmasøytisk sammensetning inneholdende kromenforbindelser | |
AU5125798A (en) | Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use | |
NO993372L (no) | Substituerte 4-(6-fluor-(1H)-indol-3-yl)-1,2,3,6-tetrahydropyridin for behandling av CNS-forstyrrelser | |
DK0853619T3 (da) | Disubstituerede piperidinderivater | |
DK0871611T3 (da) | Hidtil ukendte glycylanilidderivater, deres fremstilling og deres terapeutiske anvendelse | |
SE9901237D0 (sv) | Novel use |